![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Antiretroviral Therapy - PAHO/WHO | Pan American Health …
2021年6月28日 · Antiretroviral therapy (ART) is treatment of people infected with human immunodeficiency virus (HIV) using anti-HIV drugs. The standard treatment consists of a combination of drugs (often called "highly active antiretroviral therapy" or …
Consolidated guidelines on the use of antiretroviral drugs for
2016年6月21日 · Recommendations for a public health approach - Second edition Overview These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, …
Documents - PAHO/WHO | Pan American Health Organization
2021年6月28日 · Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV. Interim guidance; 2018 (Sólo en inglés)
HIV Drug Resistance - PAHO/WHO | Pan American Health …
2023年9月21日 · HIV drug resistance (HIVDR) is the ability of HIV to mutate and reproduce in the presence of antiretroviral (ARV) drugs. The consequences of drug resistance include treatment failure; the transmission of drug resistant HIV; as well as increased direct and indirect costs, for patients and health systems, due to more expensive, complex and toxic second- and third-line …
Concept note: Surveillance of HIV drug resistance in adults ... - PAHO
2014年7月7日 · HIV Drug Resistance (HIVDR) emerges when HIV replicates in the presence of antiretroviral drugs. If HIV drug resistance becomes widespread, the drugs currently used to treat HIV infection may become ineffective. To date, levels of HIVDR in countries scaling up antiretroviral therapy (ART) remain manageable. However, resistance is slowly increasing. In …
HIV/AIDS - PAHO/WHO | Pan American Health Organization
2024年12月17日 · The standard treatment consists of a combination of drugs (often called "highly active antiretroviral therapy" or HAART) that suppress HIV replication. The combination of drugs is used in order to increase potency and reduce the likelihood of the virus developing resistance. ART reduces mortality and morbidity rates among HIV-infected people ...
Updated recommendations on first-line and second-line …
2018年12月21日 · Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) (or emtricitabine, FTC) + efavirenz (EFV) 600 …
Guidelines for the implementation of multi-month dispensing of
2020年7月23日 · This document proposes guidelines for the prescription, distribution, and dispensing of pharmaceuticals using the multi-month dispensing modality within the framework of the Integrated Drug Supply Management System. These general guidelines can be applied to the processes of prescribing, distributing, and dispensing antiretrovirals drugs (ARVs), as well as …
More developing countries show universal access to HIV/AIDS
2010年9月28日 · Latin America and the Caribbean 18,600 (58%) had children on antiretroviral therapy in 2009, up from 17,300 in 2008 (54%). The number of facilities providing HIV testing in Latin America and the Caribbean more than doubled between 2008 and 2009, reaching 26,913, according to the countries that provided information.
Guideline on when to start antiretroviral therapy and on pre …
Overview This early-release guideline makes available two key recommendations that were developed during the revision process in 2015. First, antiretroviral therapy (ART) should be initiated in everyone living with HIV at any CD4 cell count. Second, the use of daily oral pre-exposure prophylaxis (PrEP) is recommended as a prevention choice for people at substantial …